Andrew Boll

Andrew Boll

Director of Finance/CFO at HARROW, INC.

Net worth: 29 M $ as of 2026-05-30

43 year
Health Technology
Commercial Services
Consumer Services

Profile

Andrew R.
Boll
is the founder of Surface Ophthalmics, Inc., ImprimisRx PA, Inc., Eton Pharmaceuticals, Inc., Melt Pharmaceuticals, Inc. Mr. Boll is currently President, Chief Financial Officer & Secretary at Harrow, Inc. since 2025.
Mr. Boll is a Member of CFA Institute, Institute of Management Accountants, Inc., and Cfa Society San Diego.
Formerly, Mr. Boll was a Director at Radley Pharmaceuticals, Inc. Mr. Boll completed undergraduate studies at Huron University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-13 814,679 ( 2.19% ) 29 M $ 2026-05-30

Andrew Boll active positions

CompaniesPositionStart
HARROW, INC. Director of Finance/CFO 2014-12-31
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -

Former positions of Andrew Boll

CompaniesPositionEnd
Founder -
Director/Board Member -
Founder -
Founder -
ETON PHARMACEUTICALS, INC. Founder -
See the detail of Andrew Boll's experience

Training of Andrew Boll

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

82

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Consumer Services

Commercial Services

Commercial Services

Health Technology

Retail Trade

Health Technology

Health Technology

Health Technology

Health Technology